1. Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors. (June 2017) Authors: Antonuzzo, L.; Del Re, M.; Barucca, V.; Spada, F.; Meoni, G.; Restante, G.; Danesi, R.; Di Costanzo, F.; Fazio, N. Journal: Cancer treatment reviews Issue: Volume 57(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?. (May 2016) Authors: Del Re, M.; Citi, V.; Crucitta, S.; Rofi, E.; Belcari, F.; van Schaik, R.H.; Danesi, R. Journal: Pharmacological research Issue: Volume 107(2016:May) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?. (May 2016) Authors: Del Re, M.; Citi, V.; Crucitta, S.; Rofi, E.; Belcari, F.; van Schaik, R.H.; Danesi, R. Journal: Pharmacological research Issue: Volume 107(2016:May) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0630: The role of mc4r gene polymorphisms in gbm patients treated with concomitant radio-chemotherapy. (May 2017) Authors: Cantarella, M.; Pasqualetti, F.; Gonnelli, A.; Orlandi, P.; Giuliani, D.; Delishaj, D.; Montrone, S.; Coraggio, G.; Lombardo, E.; Simeon, V.; Di Desiderio, T.; Fioravanti, A.; Fabrini, M.; Danesi, R.; Guarini, S.; Paiar, F.; Bocci, G. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck?. (29th September 2016) Authors: Danesi, R.; Del Re, M.; Ciccolini, J.; Schellens, J.H.M.; Schwab, M.; van Schaik, R.H.N.; van Kuilenburg, A.B.P. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy. (January 2018) Authors: Minari, R.; Bordi, P.; Del Re, M.; Facchinetti, F.; Mazzoni, F.; Barbieri, F.; Camerini, A.; Comin, C.E.; Gnetti, L.; Azzoni, C.; Nizzoli, R.; Bortesi, B.; Rofi, E.; Petreni, P.; Campanini, N.; Rossi, G.; Danesi, R.; Tiseo, M. Journal: Lung cancer Issue: Volume 115(2018) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms. (20th July 2015) Authors: Fontanelli, G.; Baratè, C.; Ciabatti, E.; Guerrini, F.; Grassi, S.; Del Re, M.; Morganti, R.; Petrini, I.; Arici, R.; Barsotti, S.; Metelli, M. R.; Danesi, R.; Galimberti, S. Journal: International journal of laboratory hematology Issue: Volume 37:Number 6(2015:Dec.) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Simultaneous, but not consecutive combination with folinate salts potentiates 5-fluorouracil antitumor activity in vitro. (February 2017) Authors: Di Paolo, A.; Orlandi, P.; Di Desidero, T.; Danesi, R.; Bocci, G. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗